Dr. Chamini Jayamali Perera, Ph.D. is a Lecturer and Postdoctoral Researcher at the University of New South Wales. Her current research focuses on the early detection of pancreatic cancer through the identification of possible biomarkers. This will be achieved by using in-vitro and in-vivo models of pancreatic cancer as well as 'omic' techniques to identify potential factors in small extracellular vesicles derived from pancreatic cancer and stellate cells. Once identified, the presence of lead candidate biomarkers will be tested in patients with new-onset diabetes/pancreatic cancer-related diabetes, which is now considered to be a group at 'high risk' of developing pancreatic cancer.
Prior to joining the field of Pancreatic Research, she worked in the field of Neuroscience, where she completed her Ph.D. in the field of Neuropathic pain in 2016 from the School of Medical Sciences, UNSW Medicine. During her Ph.D., he investigated immune-modulatory approaches for the treatment of neuropathic pain in animal models. Then, in her first post-doctoral years, she worked in the sensory-motor Physiology and Therapeutics (SMPT) group in the Translational Neuroscience Facility, where she aimed to identify a potential neuroprotective compound to reduce excitotoxicity following traumatic brain injury.